1. Home
  2. BMBL vs CADL Comparison

BMBL vs CADL Comparison

Compare BMBL & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bumble Inc.

BMBL

Bumble Inc.

HOLD

Current Price

$3.27

Market Cap

472.2M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.83

Market Cap

551.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMBL
CADL
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.2M
551.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BMBL
CADL
Price
$3.27
$8.83
Analyst Decision
Hold
Strong Buy
Analyst Count
13
7
Target Price
$4.46
$19.00
AVG Volume (30 Days)
3.3M
2.2M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
0.34
N/A
Revenue
$965,658,000.00
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.61
$4.35
52 Week High
$8.63
$9.26

Technical Indicators

Market Signals
Indicator
BMBL
CADL
Relative Strength Index (RSI) 35.74 75.66
Support Level $2.68 $4.80
Resistance Level $3.85 N/A
Average True Range (ATR) 0.26 0.55
MACD -0.12 0.17
Stochastic Oscillator 0.00 87.18

Price Performance

Historical Comparison
BMBL
CADL

About BMBL Bumble Inc.

Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: